Tubulis scores Series A
Munich, Germany-based Tubulis, a developer of protein-drug conjugates, has secured 10.7 million euros in Series A funding.
Munich, Germany-based Tubulis, a developer of protein-drug conjugates, has secured 10.7 million euros in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination